Skip to main content
. 2016 Nov 13;9(3):151–156. doi: 10.11138/orl/2016.9.3.151

Table 1.

Interruption of NAO therapy before surgery

Dabigatran Rivaroxaban Apixaban
Renal function Low risk High risk Low risk High risk Low risk High risk
ClCr 80ml/min 24h 48h 24h 48h 24h 48h
ClCr 50–80ml/min 36 72 24h 48h 24h 48h
ClCr 30–49ml/min 48 96 24h 48h 24h 48h
ClCr 15–30ml/min Not indicated Not indicated 36h 48h 36 48h
ClCr <15ml/min

no official data are available